Manipulating the glycosylation pathway in bacterial and lower eukaryotes for production of therapeutic proteins

- Microorganisms are a versatile platform for the production of therapeutic proteins.
- N-glycosylation engineering of fungi and bacteria produces humanlike glycans.
- Improving glycosylation efficiency in Escherichia coli is challenging.